-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, C2eZzfx+VsKySP2iPmKGRFvrd+AFselUX9CTbniWvKs4JaLEeRt15Z+ETJ+Fjatg kj5tnnXEUGNbDiSx/4MmaQ== 0000927016-98-002677.txt : 19980717 0000927016-98-002677.hdr.sgml : 19980717 ACCESSION NUMBER: 0000927016-98-002677 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19980626 ITEM INFORMATION: FILED AS OF DATE: 19980716 SROS: NYSE FILER: COMPANY DATA: COMPANY CONFORMED NAME: FRESENIUS NATIONAL MEDICAL CARE HOLDINGS INC CENTRAL INDEX KEY: 0000042872 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 133461988 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: SEC FILE NUMBER: 001-03720 FILM NUMBER: 98667288 BUSINESS ADDRESS: STREET 1: TWO LEDGEMONT CENTER STREET 2: 95 HAYDEN AVE CITY: LEXINGTON STATE: MA ZIP: 02173 BUSINESS PHONE: 6174029000 FORMER COMPANY: FORMER CONFORMED NAME: GRACE W R & CO /NY/ DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: GRACE W R & CO /CT/ DATE OF NAME CHANGE: 19900423 8-K 1 FORM 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________ FORM 8-K CURRENT REPORT PURSUANT TO SECTIONS 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 26, 1998 FRESENIUS MEDICAL CARE HOLDINGS, INC. ______________________________________ (Exact name of registrant as specified in its charter) New York -------- (State or other jurisdiction of incorporation) 1-3720 13-3461988 ------ ---------- (Commission File Number (IRS Employer Identification No.) Two Ledgemont Center, 95 Hayden Avenue Lexington, Massachusetts 02420 -------------------------------------------------------------------------- (Address or principal executive offices) (Zip Code) Registrant's telephone number, including area codes: (781) 402-9000 Not Applicable -------------- (Former name or former address, if changed since last report) ITEM 5. OTHER EVENTS Fresenius Medical Care AG, the parent corporation of Fresenius Medical Care Holdings, Inc., recently disseminated the following press release: "FRESENIUS MEDICAL CARE DIVESTS ITS DIAGNOSTICS BUSINESS Bad Homburg, Germany, July 8, 1998. Fresenius Medical Care AG (NYSE; FMS & FMSpr, Frankfurt Stock Exchange: FME & FME 3) today announced that its North American division has completed the sale of the Company's diagnostics business to Navix Radiology Systems, a private company in Coconut Grove, Florida. Udo Werle, Chief Executive Officer of Fresenius Medical Care said, "This sale completes our objective to sell the diagnostics services division, which is a non-core asset. It will allow us to focus more resources on the core renal products and services businesses." He added, "We have also signed an agreement to sell the other non-core business, homecare, and expect to complete that sale during the third quarter." Combined proceeds from the two divestitures, diagnostics and homecare, are expected to be in the range of $100 million. This will result in an estimated second quarter 1998 loss after tax from discontinued operations of approximately $100 million. The amount depends upon the finalization of the homecare transaction. Navix Radiology Systems, Inc. is a physician practice management company focused on radiology. Fresenius Medical Care AG is the world's leading integrated provider of products and services for individuals with chronic renal failure. Through its network of over 740 dialysis centers in the United States and more than 200 dialysis centers in Europe, Latin America and Asia, Fresenius Medical Care provides dialysis treatment to approximately 70,000 patients worldwide. This press release contains forward-looking statements that are subject to various risks and uncertainties. Actual results could differ materially from those contained in these forward-looking statements due to certain factors, including changes in business, economic and competitive conditions, regulatory reforms, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. These and other risks and uncertainties are detailed in the Company's reports filed with the Securities and Exchange Commission. The Company does not undertake any responsibility to update the forward-looking statements contained in this press release." SIGNATURES Pursuant to the requirements of the Securities Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. FRESENIUS MEDICAL CARE HOLDINGS, INC. /s/ Ben J. Lipps ------------------------------- DATE: July 8, 1998 Name: Ben J. Lipps Title: Chief Executive Officer 2 -----END PRIVACY-ENHANCED MESSAGE-----